Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02406781
Title Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (PEMBROSARC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonié
Indications

gastrointestinal stromal tumor

sarcoma

leiomyosarcoma

malignant fibrous histiocytoma

osteosarcoma

Therapies

Cyclophosphamide + Pembrolizumab

Cyclophosphamide + GLA-SE + Pembrolizumab

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.